pDNA Process Analytics Services

Plasmid DNA (pDNA) plays a vital role in the production of mRNA, AAV, and other therapeutic vectors, including vaccines and gene therapies.. Ensuring pDNA purity and selecting the correct isoform are crucial for these applications. Effective workflows and precise analytical methods are essential for producing high-quality pDNA, free from contaminants and meeting therapeutic standards. Advances in these methods are key to successful pDNA production and quality control. Sartorius BIA Separations experts provide comprehensive support in these areas, ensuring optimal results.

Common Challenges in pDNA Analytics

  1. Quantification Limitation: Conventional methods like agarose or capillary gel electrophoresis (CGE) separate pDNA from contaminants but do not quantify pDNA isoforms, which is essential for meeting regulatory quality specifications.
  2. False Quantification: Spectroscopic methods for quantifying nucleic acids can produce inaccurate results due to impurities that absorb UV light. Additionally, the pH and conductivity of the matrix can lead to incorrect pDNA concentration measurements.
  3. Unpredictable Linearization: Plasmid linearization using restriction enzymes can be uncertain, with variability in the required enzyme amount and reaction time.h variability in the required enzyme amount and reaction time.

With Cornerstone® services, these common challenges in pDNA manufacturing are addressed while providing solutions tailored to specific needs.

Overcoming pDNA Analytical Challenges

Integration of PATfix® analytics and complementary methods including CGE, delivers a comprehensive evaluation of pDNA samples. It allows for the quantification of different isoforms and identifying impurities.

The PATfix pDNA Platform, combined with the CIMac pDNA column, efficiently separates pDNA from contaminants and monitors pDNA isoforms during downstream processing, providing both qualitative and quantitative analyses. Additionally, this method optimizes plasmid linearization by tracking reaction kinetics, reducing time and costs, and detecting RNA impurities with high sensitivity.

  • Precise Isoform Separation
    Monolithic chromatography enables the separation and quantification of the target SC pDNA isoform from other impurities and isoforms. The CIMac pDNA columns, a weak anion exchanger, facilitate the separation of pDNA with a capacity of over 2000 μg pDNA/g biomass.
  • Accurate pDNA Quantification
    Monolithic chromatography separates pDNA from impurities, eliminating the chance of false quantification. This enables qualitative and quantitative determination of pDNA isoforms and impurities in just 17 minutes.
  • Real-Time Linearization Monitoring
    Plasmid linearization kinetics are monitored in real-time using PATfix pDNA analytics, optimizing the process to reduce time and cost.educe time and cost.

Why Choose Cornerstone pDNA Process Analytics Services?

By partnering with Cornerstone pDNA Process Analytics Services, the following benefits are offered:

  • Optimized plasmid linearization by tracking reaction kinetics, reducing time and costs.
  • Enhanced sensitivity in detecting RNA impurities.
  • Effective separation of pDNA from contaminants with precise monitoring of pDNA isoforms during downstream processing.
  • High-capacity CIMac pDNA columns handling over 2000 μg pDNA/g biomass.
  • Rapid qualitative and quantitative analyses completed in just 17 minutes.

Hear From Our Customers

The PATfix pDNA analytical platform package was helpful in getting the plasmid analysis running with validated protocols built-in the system. We have also been utilising PATfix for the analysis of IVT mRNA with validated protocols provided by Sartorius BIA Separations. We have been getting consistent and reliable results with high-throughput work processes made possible by the at-line implementation of the PATfix platform. I am happy with the system as it is easy to use, reliable and the support provided by the highly knowledgeable team at Sartorius BIA Separations and Sartorius has been excellent. I am looking forward to continuing working with the PATfix platform and the Sartorius BIA Separations team with their ongoing developments in providing high-quality analytical products. – Dae Jong Han, Research Specialist (Analytics), BASE mRNA Facility, Australia.

Read more

“By leveraging the capabilities of PATfix, I can effectively determine the ratio of empty and full capsids in our samples, thus providing valuable insights into their purity values. The software’s integration functions are designed with user-friendliness in mind, making the analysis process seamless and efficient.” – Tony Tavares, PhD | Principal Scientist. Teknova

Read more

BioNet

“We are very pleased to be collaborating with BIA Separations / Sartorius in developing and tech-transferring optimized mRNA vaccine manufacturing processes. When time is of the essence, it is crucial to be able to rely on key partners whilst maintaining the highest level of quality in every aspect of our work. We are also very proud that our team was able to produce two kinds of genetic vaccines (DNA and mRNA) and we look forward to expanding our partnership with the BIA Separations’ team on future projects.” – Hong Thai Pham, CEO, BioNet

Read more

Pharmaron

Working with Sartorius BIA Separations, Pharmaron was able to extend its toolbox of AAV purification solutions, providing multiple-modality options to achieve robust separation of genome-containing (full) from genome-free (empty) viral capsids with high purity and yield for multiple AAV serotypes. During this collaboration, a strong partnership was developed leading to Sartorius BIA separations presenting the work at the second webinar of the Pharmaron Cell and Gene Therapy webinar series. The webinar was entitled “Downstream AAV Production: A Targeted Approach to Optimization”.

Read more

Theriva Biologics

“I highly appreciated the willingness of each expert from different monoliths and various applications to support our work, explain new methods, introduce new approaches, and offer further technical support in our product development. I feel like I can really delve into the depths of product characterization, and I believe I can gain much more data from the PATfix system, which I’m really eager to explore in the future.” – Sonia Celej, Bioprocess Development Specialist, Theriva Biologics

Read more

Ready to Discuss Your Project?

FAQ About Services for pDNA Process Analytics

The facilities are located in Ajdovščina, Slovenia. Support for process development is available in modern, fully equipped BSL 1 and 2 facilities. A virtual tour of the laboratories is available.

The pDNA platform is a versatile solution capable of analyzing various pDNA samples, from alkaline lysates to purified pDNA. No pre-treatment is needed, only dilution with a loading buffer is required.

For more information about the role of analytics in the plasmid production process, follow the link below

Learn More

Yes, the specially designed monolith column with 6 µm channels enables the analysis of large plasmids with excellent isoform recovery. The large channels prevent the physical entrapment of the large OC isoform while maintaining high resolution between pDNA isoforms.

Yes, the chromatographic method is validated following FDA and EMA guidelines, using commercially available pFix5 and pFix15  pDNA standards.

As an orthogonal method to chromatographic evaluation, we offer pDNA testing by CGE, including method development tailored to the specific needs of your project.

Consult Our Experts

Our experts would be happy to discuss your project. Fill the contact form below or send us an email to cornerstone@biaseparations.com

    Povpraševanje za izdelek

    Fields marked with * are required!

    0
      0
      Your Cart
      Your cart is emptyReturn to Homepage
        This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.